Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2355]

ASCO GU 2026: Updates in metastatic prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ASCO GU 2026: Updates in metastatic prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

ASCO GU 2026: Updates in localised prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ASCO GU 2026: Updates in localised prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

ASCO GU 2026: Latest updates in mRCC

Dr Toni Choueiri, Prof Viktor Grünwald, Dr Stephanie Berg, Dr Cristina Suárez...

ASCO GU 2026: Latest updates in mRCC ( Dr Toni Choueiri, Prof Viktor Grünwald, Dr Stephanie Berg, Dr Cristina Suárez and Dr Guillermo de Velasco )

Post-orchiectomy miR-371 predicts recurrence in clinical stage I testicular...

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia,

Post-orchiectomy miR-371 predicts recurrence in clinical stage I testicular germ cell tumours during active surveillance ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia, )

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle...

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )

Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or...

Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA

$Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma ( Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA )$

Climate and environmental factors drive seasonal risk of invasive mucormycosis...

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA

Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )

Extreme heat exposure around diagnosis is linked to higher mortality in...

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA

Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC ( Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA )

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD...

Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform ( Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA )

Exploring genetic essentiality and drug sensitivity in triple-negative breast...

Dr Ricardo Pinto - i3S, Porto, Portugal

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer ( Dr Ricardo Pinto - i3S, Porto, Portugal )

Improving African representation in breast cancer genomics

Dr Ricardo Pinto - i3S, Porto, Portugal

Improving African representation in breast cancer genomics ( Dr Ricardo Pinto - i3S, Porto, Portugal )

More from ecancer